| Nov 1 |
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
|
| Nov 1 |
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
|
| Nov 1 |
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Oct 28 |
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
|
| Oct 28 |
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
|
| Oct 25 |
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
|
| Oct 23 |
Nexalin trials Halo neurostimulation device in traumatic brain injury
|
| Oct 22 |
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
|
| Oct 18 |
Mixed results for Nexalin’s transcranial alternating current stimulation trial
|
| Oct 17 |
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients
|
